WILLIAM L. WINTERS, M.D.; PAUL S. RHOADS, M.D.; WAYNE W. FOX, M.D.; RENO ROSI, M.D.
The purpose of this paper is to report our experience with sulfapyridine in the treatment of 123 cases of lobar pneumonia in adults during the period from January 15 to May 15, 1939. During the past year many clinical reports on the treatment of pneumonia with sulfapyridine have appeared in the literature. Generally, the mortality rate has been reduced from 25 per cent to 30 per cent to below 10 per cent. Pepper et al.1 reported 400 cases of pneumococcic pneumonia treated with sulfapyridine with a mortality of 7 per cent. Gaisford2 reported 400 cases with a mortality of 6.5
WINTERS WL, RHOADS PS, FOX WW, ROSI R. THE TREATMENT OF PNEUMOCOCCIC PNEUMONIA WITH SULFAPYRIDINE1. Ann Intern Med. ;14:1827–1837. doi: 10.7326/0003-4819-14-10-1827
Download citation file:
Published: Ann Intern Med. 1941;14(10):1827-1837.
Infectious Disease, Pneumonia, Pulmonary/Critical Care.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use